Walker Luke Nathaniel — SEC Form 4 Insider Trading Activity

Summary

Updated Jul 16, 2026

Walker Luke Nathaniel has filed 2 SEC Form 4 filings across 2 companies in the last 90 days.

Profile

Walker Luke Nathaniel is listed as a director of Zentalis Pharmaceuticals, Inc. in SEC filings with the most recent filing date of June 18, 2026. Public disclosures provide limited information about his background beyond his board assignment. No additional corroborated biographical details are readily available from the provided SEC filings.

Board memberships

• Zentalis Pharmaceuticals, Inc.

Awards & honors

• Serves as a director at Zentalis Pharmaceuticals, Inc. per SEC filings (2026)

Recent Transactions

Companies — Last 90 Days

• Context Therapeutics Inc. (CNTX) — 1 filings, last 2026-06-26
• Zentalis Pharmaceuticals, Inc. (ZNTL) — 1 filings, last 2026-06-18

Frequently Asked Questions

Who is Walker Luke Nathaniel?

Walker Luke Nathaniel is listed as a director of Zentalis Pharmaceuticals, Inc. in SEC filings with the most recent filing date of June 18, 2026. Public disclosures provide limited information about his background beyond his board assignment. No additional corroborated biographical details are readily available from the provided SEC filings.…

How many SEC Form 4 filings has Walker Luke Nathaniel submitted recently?

2 primary Form 4 filings in the last 90 days, covering 2 companies.

Where can I see all of Walker Luke Nathaniel's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

• What is SEC Form 4?
• How to read insider buying signals
• Understanding Rule 10b5-1 trading plans
• Browse all insiders
• Most active insiders this week